
Curaleaf International Extends Device Availability to New Zealand
Curaleaf International announced a TGA-registered liquid medical cannabis inhalation device in Australia and availability extended to New Zealand.
Read Article →ROOK INDUSTRY NEWS
Stay current on the companies, products, approvals and industry moves shaping medical sales.

Curaleaf International announced a TGA-registered liquid medical cannabis inhalation device in Australia and availability extended to New Zealand.
Read Article →
Thepharmaletter reports a planned Phase III trial of Datroway with ivonescimab in first-line triple-negative breast cancer.
Read Article →
SGGP reports the Ministry of Health plans to expand nearly 700 active ingredients at the primary healthcare level and study equipment price management.
Read Article →
Emjreviews reports FDA approval of a gene therapy for Sanfilippo syndrome and highlights pediatric clinical trial data.
Read Article →
Dispatch reports Bayer will invest $2.2 billion in a New Albany pharmaceutical plant, its first manufacturing site of this kind in North America.
Read Article →
Abogen Biosciences granted Novartis an exclusive worldwide license to ABO2203, with options for further RNA-platform programs.
Read Article →